Study Design
tumors
ONCOLOGY, METASTASIS, TUMORS
The current study is a randomized, superiority, two-arm, interventional trial involving nine Italian referral centers from the Italian Society of Surgical Oncology (SICO). All consecutive patients with RSCC located between the cecum and proximal third of the transverse colon without distant metastasis were eligible for enrollment in the trial. Patients needed to meet the following inclusion criteria: age 18–85 years, tumors clinically staged as cT2-4aN0 or cT1-4aN+ according to preoperative staging, American Society of Anesthesiologists (ASA) physical status score lower than 4, body mass index (BMI) of 30 kg/mThis study was conducted in accordance with CONSORT guidelines